BIOVIA Generative Therapeutics Design (GTD): AI/ML-Powered Drug Discovery

Join us for an engaging 4-hour webinar on Generative Therapeutics Design (GTD), a cutting-edge AI/ML-driven approach for exploring chemical space and automating the discovery of novel small molecule drug candidates. In this session, you will learn how to leverage machine learning models alongside structure-based modeling to perform virtual screening, optimize candidate compounds, and accelerate the drug discovery process. You will also explore multi-parameter optimization, balancing key factors such as 3D descriptors (docking, pharmacophore features), pharmacokinetics, pharmacodynamics, ADME properties, bioavailability, drug metabolism, and more.

​​​​​​​Webinar Highlights:

• AI/ML-Powered Candidate Discovery: Use generative models to identify and optimize novel small molecule drug candidates.
• Structure-Based Design for Precision: Integrate molecular docking and pharmacophore modeling to guide compound optimization.
• Multi-Parameter Optimization: Balance pharmacokinetic, pharmacodynamic, and drug metabolism properties for effective and safe drug design.